Black Rock Inc. Kiora Pharmaceuticals Inc Transaction History

Black Rock Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.12 - $64.44 $2,517 - $1.35 Million	-20,981 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$0.86 - $2.11 $18,043 - $44,269	20,981 New	20,981 $32,000

Ticker KPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 919,078
Market Cap $3.43M
Description
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.